Humanistic Care in Patients With Coronavirus Disease 2019

NCT04283825 | Withdrawn

• 1 other identifier: XJTU2H-WH1
• Study Type: interventional
• Target: N/A
• Locations: 0 countries
• Sites: N/A

Brief Summary

As of February 17th, 2020, China has 76396 confirmed cases of coronavirus disease 2019 (COVID-19), including 2348 deaths. Although the impact factors of clinical outcomes among hospitalized patients still need to be clarified, some of the therapeutic regimens have shown the potency in the treatment of severe cases. Investigators aim to evaluate the efficacy of psychological and physical rehabilitation based humanistic care in the treatment of COVID-2019.

Conditions

Coronavirus Disease 2019

Keywords

coronavirus disease 2019; physical rehabilitation; psychological rehabilitation

Outcome Measures

Primary Outcomes (1)

• Recovery Time

  Time for recovery from admission to discharged

  1 month

Secondary Outcomes (2)

• Self-rating depression scale

  1 month

• Survival rate

  1 month

Study Arms (2)

Humanistic care

EXPERIMENTAL

In addition to routine therapy, the combinations of different psychological and physical rehabilitation activities will be applied to the patients.

Behavioral: Psychological and physical rehabilitation based humanistic care

Non-humanistic care

NO INTERVENTION

Patients only receive routine therapy.

Interventions

Psychological and physical rehabilitation based humanistic care BEHAVIORAL

This Psychological and physical rehabilitation based humanistic care regimen is generated from the experience of the National medical team members in Wuhan, from our hospital. In addition to the routine therapy, we will apply this comprehensive humanistic care regimen to the patients according to their condition. The patients will be stratified by the severity and receive different combinations of Psychological and physical rehabilitation activities.

Humanistic care

Eligibility Criteria

• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

• Inpatients with 2019 Novel Coronavirus infection

You may not qualify if:

• Patients can not follow-up;
• Investigator considering inappropriate.

Sponsors & Collaborators

• Second Affiliated Hospital of Xi'an Jiaotong University: lead

MeSH Terms

Conditions

COVID-19

Condition Hierarchy (Ancestors)

Pneumonia, Viral; Pneumonia; Respiratory Tract Infections; Infections; Virus Diseases; Coronavirus Infections; Coronaviridae Infections; Nidovirales Infections; RNA Virus Infections; Lung Diseases; Respiratory Tract Diseases

Study Officials

• Shouping Gong, MD, PhD

  Second Affiliated Hospital of Xi'an Jiaotong University

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NON RANDOMIZED
• Masking: NONE
• Purpose: SUPPORTIVE CARE
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: February 22, 2020
• First Posted: February 25, 2020
• Study Start: February 22, 2020
• Primary Completion: April 30, 2020
• Study Completion: May 15, 2020
• Last Updated: March 17, 2020

Record last verified: 2020-02

Data Sharing

• IPD Sharing: Will not share